Ticker Details
Tarsus Pharmaceuticals, Inc. Common Stock
IPO Date:	October 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.83B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.80 | 2.66%
Avg Daily Range (30 D):	$1.44 | 2.14%
Avg Daily Range (90 D):	$1.38 | 1.91%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	.51M
Avg Daily Volume (90 D):	.45M

Trade Size
Avg Trade Size (Sh.):	56
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	1,540
Avg Institutional Trade:	$3.01M
Avg Institutional Trade (30 D):	$3.18M
Avg Institutional Trade (90 D):	$4.77M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.2M
Avg Closing Trade (30 D):	$4.97M
Avg Closing Trade (90 D):	$4.8M
Avg Closing Volume:	76.97K

News

Oct 28, 2025 @ 9:00 PM Tarsus to Report Third Quarter 2025 Financial Resu... Source: Tarsus Pharmaceuticals, Inc.

Oct 27, 2025 @ 3:15 PM Capricorn Fund Loads Up on Phreesia (PHR) With a 4... Source: Cory Renauer

Oct 1, 2025 @ 5:00 PM Lyme Disease Market Growth Highlighted by Pipeline... Source: Delveinsight

Aug 27, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Tarsus Pharmaceuticals, Inc.

Aug 27, 2025 @ 8:26 AM 3 Biotech Catalysts Present Major Opportunity Source: Nathan Reiff

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.99	$-.3	$-.48
Diluted EPS	$-1.99	$-.3	$-.48
Revenue	$366.1M	$118.7M	$102.66M
Gross Profit
Net Income / Loss	$-81.16M	$-12.59M	$-20.34M
Operating Income / Loss	$-87.41M	$-14.53M	$-22.18M
Cost of Revenue
Net Cash Flow	$-60.92M	$16.08M	$-79.14M
PE Ratio